NEW YORK--(BUSINESS WIRE)--Centinel Spine, Inc. (Centinel), a market leader in the development, manufacture and distribution of Integrated Interbody Fusion™ devices, today announced a record 41.8% revenue increase during the 4th quarter, 2010, vs. 3rd quarter, 2010. Also, during the 4th quarter, 2010, Centinel achieved a record setting 32.5% gain vs. the same period in 2009.
Announcing the results, Centinel’s Chairman and CEO, John J. Viscogliosi, said, “We are extremely pleased, but certainly not surprised, by Q4’s huge revenue increase and record results. A confluence of positive events continued for us in the 4th quarter as we initiated our new STALIF MIDLINE™ alpha launch, while support from surgeons using our STALIF C™ and STALIF TT™ Integrated Interbody fusion devices continued on an exponential growth path. Looking forward, we fully expect the first quarter of this year and the balance of 2011 to continue with similar stellar results.”
Commenting on the results, Centinel’s President, Michael D. Will, said, “There are many new and varied options available for patients and their surgeons in the treatment of spinal disc problems, however, surgeons are finding Centinel’s ground-breaking implant designs are as relevant or more-so today than when they were first introduced.”
Mr. Will added: “With the continued evolution of our STALIF line of products, more and more surgeons are recommending Centinel’s solutions and great products are what ultimately drive growth.”
About Centinel Spine, Inc.
Founded in 2008, Centinel Spine, Inc. is an innovative spinal device company committed to the design and development of simple, biomechanically sound solutions for spinal stabilization and fusion. The company is recognized as a leader in the expanding Integrated Interbody Fusion spinal market segment.
STALIF™, STALIF TT™, STALIF MIDLINE™, STALIF C™, Lag Effect Fixation™, ABO™ and Integrated Interbody Fusion™ are registered trademarks or trademarks of Centinel Spine, Inc. in the United States and/or other countries.
For more information on Centinel Spine: http://www.centinelspine.com/
Forward-looking statements
This news release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting Centinel Spine’s business including increased competition; the ability of Centinel Spine to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.